PHYSIOLOGICALLY-BASED PHARMACOKINETIC ANALYSES OF SIMPLE MIXTURES

被引:33
|
作者
KRISHNAN, K
CLEWELL, HJ
ANDERSEN, ME
机构
[1] UNIV MONTREAL,FAC MED,DEPT MED TRAVAIL & HYG MILIEU,MONTREAL,PQ,CANADA
[2] CHEM IND INST TOXICOL,RES TRIANGLE PK,NC
[3] MANTECH ENVIRONM TECHNOL INC,DAYTON,OH
关键词
PHYSIOLOGICAL PHARMACOKINETICS; PBPK MODELING; CHEMICAL MIXTURES; TOXICOKINETIC INTERACTION;
D O I
10.1289/ehp.94102s9151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Exposure to multiple chemicals may cause significant alterations of tissue dose of the toxic moiety of one or more of the individual chemicals. The change in target tissue dose of a chemical present in simple mixtures can be predicted when the determinants of disposition of each chemical, and the mechanism of toxicokinetic interaction between chemicals are understood at a quantitative level. Determinants of disposition include physiological (e.g., breathing rates, cardiac output, tissue volumes, blood flow rates), biochemical (e.g., kinetic constants for metabolism and protein binding), and physicochemical factors (e.g., blood:air and tissue:blood partition coefficients). Mechanisms of toxicokinetic interactions refer to the manner in which coexposure alters these determinants of disposition as compared to exposure to the individual chemicals. Interactions between chemicals can be described quantitatively with physiologically based pharmacokinetic (PBPK) models, which integrate these mechanistic determinants and permit prediction of alterations in tissue dose for various exposure situations by computer simulation. PBPK modeling studies of binary chemical interactions conducted so far indicate that inhibitory rather than potentiating metabolic interactions are more likely to be observed during multiple chemical exposures. As PBPK models of representative binary, tertiary and quaternary mixtures are developed, it will become increasingly possible to draw reliable conclusions about the risk associated with human exposure to chemical mixtures.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [1] The use of physiologically-based pharmacokinetic pharmacodynamic dosimetry models for chemical mixtures
    Yang, RSH
    ElMasri, HA
    Thomas, RS
    Constan, AA
    TOXICOLOGY LETTERS, 1995, 82-3 : 497 - 504
  • [2] Physiologically-based pharmacokinetic simulation modelling
    Grass, GM
    Sinko, PJ
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 433 - 451
  • [3] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR PREGNANCY
    Liu, X.
    Leong, R.
    Buckart, G.
    Dallmann, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S117 - S117
  • [4] An introduction to physiologically-based pharmacokinetic models
    Upton, Richard N.
    Foster, David J. R.
    Abuhelwa, Ahmad Y.
    PEDIATRIC ANESTHESIA, 2016, 26 (11) : 1036 - 1046
  • [5] Physiologically-based pharmacokinetic analysis of grepafloxacin
    Nakajima, Y
    Hattori, K
    Shinsei, M
    Matsunaga, N
    Iizasa, H
    Sasabe, H
    Akiyama, H
    Miyamoto, G
    Nakashima, E
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (09) : 1077 - 1083
  • [6] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [8] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE ANTIBIOTIC ERTAPENEM
    Joyner, Michele L.
    Manning, Cammey C.
    Forbes, Whitney
    Maiden, Michelle
    Nikas, Ariel N.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2016, 13 (01) : 119 - 133
  • [9] Pharmacokinetics and Physiologically-Based Pharmacokinetic Modeling of Nanoparticles
    Yang, Raymond S. H.
    Chang, Louis W.
    Yang, Chung Shi
    Lin, Pinpin
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2010, 10 (12) : 8482 - 8490
  • [10] Have physiologically-based pharmacokinetic models delivered?
    Edginton, Andrea N.
    Joshi, Ghanashyam
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (08) : 929 - 934